Tesamorelin peptide therapy
5 things to know about Tesamorelin
A growth-hormone-releasing peptide studied in randomized clinical trials for visceral belly fat. Prescribed by a licensed clinician, lab tested, and delivered in a pre-filled pen.
- Third-party tested
- Ongoing care team
- Pharmacy compounded
- Free 2-day shipping
Takes under 2 minutes · 100% private · No insurance required

$449 $224 50% off
What to know about Tesamorelin
You're eating right. You're hitting the gym. You're doing the work. But staying lean after 40 isn't as easy as it used to be.
That is one reason Tesamorelin gets so much attention. It works through the body's growth hormone pathway, and unlike many peptides, it has been tested in randomized clinical trials.
Here are five things to know before you ask a clinician about it.

01of 05
It works through your body's own growth hormone pathway
Tesamorelin is a lab-made analog of growth hormone-releasing hormone, or GHRH. Rather than supplying growth hormone directly, it prompts your pituitary gland to release more of its own.
- Peptide
- Tesamorelin, a 44-amino-acid GHRH analog
- In each pen
- 30 mg, a one-month supply
- Form
- Pre-filled pen with a twist-to-dose selector
- Category
- Performance

02of 05
It targets visceral belly fat, not just the scale
Visceral fat is the deep fat stored around your organs. In trials of adults with HIV-associated lipodystrophy, Tesamorelin reduced it while measured lean mass rose. Those results haven't been established in otherwise healthy people.
Visceral fat reduction
Tesamorelin has been clinically shown to reduce excess abdominal visceral fat in adults with HIV and lipodystrophy.
Muscle support
Targets the growth hormone pathway, which plays a role in maintaining lean tissue and supporting recovery.
Lean body composition
May support changes in body composition through its effects on growth hormone signaling and visceral fat.
15.2%
less visceral fat
In a 26-week trial of 412 adults with HIV, visceral fat fell 15.2% on Tesamorelin versus a 5.0% rise on placebo.
26
weeks in the main trials
Results were measured at 26 weeks. Body weight barely changed, and the fat crept back in patients switched to placebo.
1
FDA-approved use
As Egrifta, it is approved only to reduce excess abdominal fat in adults with HIV and lipodystrophy, not for weight loss.
S2
on WADA's list
Tesamorelin is banned in sport at all times, listed among GHRH analogs on WADA's 2026 Prohibited List.
03of 05
It has randomized clinical research behind it
Unlike many peptides, Tesamorelin has been tested in randomized, placebo-controlled human trials, and an FDA-approved form exists for one specific use. That approval doesn't cover general weight loss, muscle building or anti-aging.
Tesamorelin can raise IGF-1, affect blood sugar, and cause side effects such as fluid retention and joint discomfort. That is why every Peppi prescription starts with a clinician review of your intake.
Results come in stages.
Week 1
Build the routine
Set a baseline for sleep, recovery, training, energy, and body composition. Commit to following the plan consistently.
Weeks 2–4
Feel early signals
Pay attention to changes in sleep, recovery, energy, and how you feel going into your workouts.
Months 2–3
See real progress
Changes in recovery, training consistency, waist measurement, or body composition may become easier to measure.
Months 4–6
Sustain the benefit
The goal is lasting results that show up in how you look, feel, and perform.
Peptide therapy is cumulative. We recommend patients commit 4‑6 months for results to build.
*Applies only if a practitioner prescribes treatment. Onset and response vary by individual; statements pending medical review and are not a guarantee of outcomes.
04of 05
Results come in stages
Peptide therapy is cumulative. Here's what Peppi tells patients to expect over the first six months, if a clinician prescribes it.
05of 05
Peppi makes it one pre-filled, tested pen
No vials, no mixing and no guesswork. Each pen holds a one-month supply, every batch is lab tested before it ships, and a licensed clinician sets your dose.
The Tesamorelin pen
Everything you need, in one pen
Shop all peptidesOne pen, eight peptides. Pick yours:

Tesamorelin 30 mg peptide pen
Tesamorelin
TESAMORELIN 30 MG
Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH).
Studied for:
Add to cartFull refund if your prescription isn't approved
- Third-party tested
- Ongoing care team
- Pharmacy compounded
- Free 2-day shipping
Third-party lab tested peptides
What's in the pen matters. So does where it comes from.
Your peptides shouldn't come with guesswork. Peppi's prescription protocols are clinician-reviewed, filled by licensed U.S. pharmacies, and lab tested before they reach your door.
- Sourced from licensed U.S. pharmacies
- Clinician-reviewed prescriptions
- Pharmaceutical-grade ingredients only
- Batch-tested before shipping
Testing performed by Accumark Labs and Atlas Analytics, independent third-party laboratories
Peppi pens vs “research use only” peptides
How Peppi compares
| Peppi | Research-use-only peptides | |
|---|---|---|
| For human use | Yes | No |
| Pre-filled & pre-mixed | Yes | No |
| Easy dosing | Yes | No |
| Prescribed by a clinician | Yes | No |
| Dispensed from a pharmacy | Yes | No |
| Third-party lab tested | Yes | No |
| Ongoing care team | Yes | No |
Not sure where to start?
Answer a few questions and we'll tell you where to start.
How online peptide prescriptions work
From quiz to your door in 2–3 days
Step 1 Today
Answer a few questions. We'll handle the rest.
- No commitment required
- 100% online, takes under 2 minutes
- 100% private and secure
Step 2 Within 24 hours
A real clinician builds your plan.
- Dosing personalized from day one
- Peptides matched to your body and goals
- Licensed, certified clinicians
Step 3 Within 2–3 days
Everything you need. Delivered to your door.
- Direct from a U.S. pharmacy
- Free 2-day shipping
- Your pen, supplies, care team, and personalized plan
Step 4 Every 28 days
Your plan evolves with your goals.
- Unlimited video calls & messaging with your care team
- Simple refills & adjustments
- Pause or cancel anytime
Tesamorelin FAQs
Frequently asked questions
What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone that prompts the pituitary to release more growth hormone. Under the brand Egrifta, it is FDA approved only to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, and that approval covers the Egrifta brand. At Peppi, a licensed clinician decides whether Tesamorelin fits you.
Does Tesamorelin work?
Tesamorelin does reduce visceral fat in clinical trials, mostly in adults with HIV. In a 26-week trial of 412 patients, visceral fat fell 15.2% versus a 5.0% rise on placebo, and a 2012 obesity trial in 60 adults found less too. Body weight barely changed, and the fat crept back in patients switched to placebo.
How long does Tesamorelin take to work?
Tesamorelin's main trials measured results at 26 weeks, when visceral fat in adults with HIV had dropped 15.2% compared with a rise on placebo. A later trial in adults with obesity ran a full 12 months. Peppi recommends committing 4 to 6 months, since peptide therapy is cumulative and response varies from person to person.
Is Tesamorelin FDA approved?
Tesamorelin is FDA approved, but only as the brand Egrifta for one use: reducing excess abdominal fat in adults with HIV and lipodystrophy. FDA first approved it in 2010, and the Egrifta WR label, revised in March 2025, says it isn't meant for weight loss. A Peppi clinician can explain what that means for you.
Does Tesamorelin help build muscle?
Tesamorelin isn't proven to build muscle in healthy people. In its HIV trials, lean body mass rose about 1.2 to 1.3 kg over 26 weeks while placebo groups lost slightly, and a later analysis found larger, denser trunk muscles. We found no trial in healthy lifters, and WADA's 2026 list bans it at all times.
Is Tesamorelin a GLP-1?
Tesamorelin is not a GLP-1. It's a growth hormone-releasing hormone analog that prompts the pituitary to release growth hormone, while GLP-1 medicines mimic a gut hormone that curbs hunger and slows digestion. The difference shows on the scale, since Tesamorelin's label calls it weight neutral, trimming visceral fat without much change in body weight.
Can women take Tesamorelin?
Women can take Tesamorelin, and women took part in its trials, though in smaller numbers. Women made up about 14% of the 412 adults in the main 2007 HIV trial and 21 of 60 adults in a 2012 obesity trial. The label rules it out during pregnancy, which a Peppi clinician checks before prescribing.
Does Tesamorelin need to be refrigerated?
Yes. Your Peppi Tesamorelin pen needs to be kept in the refrigerator. Follow the storage directions that come with your pen, and note that every order ships in temperature-controlled packaging.
Have more questions?
Email: [email protected]
Call: +1 302-499-3831
Tesamorelin articles & guides
Read more about Tesamorelin
ComparisonTesamorelin vs MOTS-c: Two peptide paths to a leaner body
Tesamorelin has human trials for visceral fat in HIV lipodystrophy, while MOTS-c research is mostly in mice. Compare the evidence, pens and fit.
Peppi HealthOct 23, 2026
Listicle5 peptides for fat loss that are not GLP-1s
Tesamorelin, MOTS-c, CJC-1295, Ipamorelin and sermorelin: how each is studied for fat loss, and how strong the evidence really is.
Peppi HealthOct 23, 2026
Listicle7 best peptides for muscle growth & recovery
Seven peptides for muscle growth and recovery, from CJC-1295 and Tesamorelin to BPC-157, with how strong each one's research really is.
Peppi HealthOct 22, 2026
Get Tesamorelin prescribed online
Is Tesamorelin right for you?
The next step is to talk to a licensed clinician. Answer a few questions, and a clinician reviews your health history and builds your plan within 24 hours.
100% refund if prescription is not approved

Important safety information
Prescription treatment is subject to independent medical evaluation and applicable legal requirements. Tesamorelin's FDA-approved indication, as the brand Egrifta, is reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight loss, muscle building, or anti-aging, and Peppi's Tesamorelin pen is not an FDA-approved drug. Research in otherwise healthy adults is limited. Treatment carries risks and may not be appropriate for everyone, and Tesamorelin is prohibited in tested sport.

